(Press-News.org)
WASHINGTON (July 5, 2023) – A new multicenter, single-arm, open-label study is the first to exclusively assess bleeding complications in patients undergoing high-risk percutaneous coronary interventions (PCI) with Impella with independent adjudication via a clinical events adjudication committee and will gather meaningful real-world data based on contemporary practice. The design and rationale of the study was published online today in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI).
Nearly one in every five patients1 will experience a bleeding complication during a large-bore endovascular procedure. Periprocedural bleeding is the most common complication in patients undergoing PCI and is associated with a significantly increased risk of mortality, morbidity, and cost.
The Design and Rationale of the Safe Surveillance of PCI Under Mechanical Circulatory Support with the Saranas Early Bird Bleed Monitoring System (SAFE-MCS) study evaluates the safety of complex high-risk PCI using the Impella Heart Pump in conjunction with the Saranas Early Bird Bleed Monitoring System (EBBMS). The study will enroll a total of 184 evaluable subjects at up to 15 U.S. centers. Evaluable subjects are defined as all participants who had EBBMS placed ipsilateral to mechanical circulatory support and had post-procedure monitoring with EBBMS for a minimum of two hours.
The Saranas EBBMS includes a bleed detection array with integrated electrodes in a fully functional vascular access sheath. It is designed to measure changes in bioimpedance to detect and monitor bleeding from vessel injury.
The primary clinical endpoint is the incidence of access site-related Bleeding Academic Research Consortium (BARC) type III or V bleeding. Secondary clinical endpoints include the incidence of each Saranas EBBMS level 1, 2, and 3 indicators, and the incidence of all BARC type III or V bleeding.
The study authors note that in addition to the main clinical study, data from the SAFE-MCS study will also be used to perform an economic analysis of the potential economic benefit of the Saranas EBBMS.
“SAFE-MCS is the first study dedicated to evaluating bleeding events post-Impella use and will bring meaningful important insight on the rates of bleeding events during those procedures. While most of the studies on MCS devices focus on efficacy outcomes, SAFE-MCS focuses on safety and risk mitigation, and outcomes which are very important for patients, care givers, and the healthcare system in general” stated Dr. Philippe Généreux, MD, from Gagnon Cardiovascular Institute at Morristown Medical Center, New Jersey, lead author, and co-principal investigator of the study. Généreux noted that while this study focuses on stable patients undergoing high-risk PCI, the role of early bleeding detection is even more important in an emergency such as cardiogenic shock, ST-elevated myocardial infarction, and during ECMO initiation.
“Timely identification of bleeding events is crucial in preventing adverse events that can have serious consequences for patients. The data from SAFE-MCS will provide meaningful guidance on how real-time monitoring can improve clinical outcomes through a proactive approach to managing bleeding risk,” said Dr. Babar Basir, Director of Acute Mechanical Circulatory Support at Henry Ford Health System, and co-principal investigator of SAFE-MCS.
Authors note that the study is anticipated to finish enrollment by the end of 2023.
The SAFE-MCS study is funded by Saranas, Inc., with an independent clinical events adjudication committee (Cardiovascular Research Foundation) and an independent imaging core laboratory (Medical Metrics).
###
About SCAI:
The Society for Cardiovascular Angiography & Interventions (SCAI) is a nonprofit professional association with over 5,000 members representing interventional cardiologists and cardiac catheterization teams in the United States. SCAI promotes excellence in interventional cardiovascular medicine for both adults and children through education, representation, and the advancement of quality standards to enhance patient care.
References
Björn Redfors, MD, PhD; Brendan M. Watson, MD, PhD; Thomas McAndrew, PhD; et al (2017). Mortality, Length of Stay, and Cost Implications of Procedural Bleeding After Percutaneous Interventions Using Large-Bore Catheters. JAMA Cardiol. 2017;2(7):798-802. doi:10.1001/jamacardio.2017.0265 END
SAN ANTONIO — July 5, 2023 —The Southwest Research Institute-led Ultraviolet Spectrograph (UVS) aboard ESA’s Jupiter Icy Moons Explorer (JUICE) spacecraft has successfully completed its initial commissioning following the April 14 launch. The UVS instrument is one of three instrument projects comprising NASA’s contribution to the JUICE mission. The mission’s science goals focus on Jupiter and its system, making multiple flybys of the planet’s large, ocean-bearing satellites with a particular emphasis on investigating Ganymede ...
The first clinical trial of a three-month tuberculosis (TB) treatment regimen is closing enrollment because of a high rate of unfavorable outcomes with the investigational course of treatment. AIDS Clinical Trials Group 5362, also known as the CLO-FAST trial, sought to evaluate the safety and efficacy of a three-month clofazimine- and high-dose rifapentine-containing regimen. An interim data analysis showed that participants taking the investigational regimen experienced ongoing or recurring TB at rates above thresholds set in the study protocol. Based on these findings, ...
Voters in North Atlantic Treaty Organization (NATO) member states are far more willing to militarily defend another country if the country joins NATO, versus if the same country does not join NATO, according to a study. To explore the possible consequences of expanding NATO membership, Michael Tomz and colleagues surveyed 14,000 voters in 13 NATO countries. Each survey participant was presented with a hypothetical Russian attack on one of four possible targets: Bosnia, Finland, Georgia, or Sweden—the four countries (other than Ukraine) furthest along in their bids for NATO accession at the time of ...
The Icahn School of Medicine at Mount Sinai has launched the Center for Ophthalmic Artificial Intelligence and Human Health, the first of its kind in New York and one of the first in the United States. The Center is dedicated to advancing artificial intelligence (AI) in the field of ophthalmology, further positioning the Mount Sinai Health System as a leader in providing patient care through pioneering innovations and technologies.
In partnership with the Windreich Department of Artificial Intelligence and Human Health at Icahn Mount Sinai, the Center aims to ...
New research reveals that sunscreen contamination may be less harmful to wildlife than previously thought. This study by Aaron Boyd, a PhD candidate at the University of Alberta in Edmonton, Canada, demonstrates how exposure to sunscreen is actually a low risk for small aquatic animals compared to some of the suncream’s individual chemicals.
Sunscreens contain ultraviolet filters (UVFs) which have been found to be toxic to marine life such as corals, leading to the ban of some UVFs in Hawaii and Palau. If sunscreen is applied to the skin before swimming in lakes and rivers, these UVFs and other chemicals will leach into surrounding waters.
Mr ...
Researchers have been testing real-life Batman-style gadgets to eradicate moth pests from greenhouses, including bat-inspired flying drones that hunt down and destroy moths – but new research reveals that the noise from drones can alter moth flight behaviour.
“The idea of using drones as an alternative solution to eliminating moths all started in the bedroom of one of the co-owners of the PATS startup company,” says Dayo Jansen, a PhD student from student from Wageningen University and Research in the Netherlands. ...
Embargoed until 8 a.m. ET/ 7 a.m. CT on Wednesday, July 5, 2023
DALLAS, July 5, 2023 — The COVID-19 pandemic radically changed the way health care professionals serve their patients. Over the past three years, a huge proportion of care has shifted to the virtual landscape as clinicians and patients search for a safe, reliable way to receive needed care.[1]
As part of its longstanding commitment to ensuring equitable access to high-quality health care, the American Heart Association has launched its first individual ...
Imagine a world where computers can unravel the mysteries of quantum mechanics, enabling us to study the behavior of complex materials or simulate the intricate dynamics of molecules with unprecedented accuracy.
Thanks to a pioneering study led by Professor Zoe Holmes and her team at EPFL, we are now closer to that becoming a reality. Working with researchers at Caltech, the Free University of Berlin, and the Los Alamos National Laboratory, they have found a new way to teach a quantum computer how to understand and predict the behavior of quantum systems, even with a few simple examples.
Quantum neural networks (QNNs)
The researchers worked on “quantum neural networks” ...
CHAMPAIGN, Ill. — Engineers at the University of Illinois Urbana-Champaign have developed a new test that can predict the durability of cement in seconds to minutes – rather than the hours it takes using current methods. The test measures the behavior of water droplets on cement surfaces using computer vision on a device that costs less than $200. The researchers said the new study could help the cement industry move toward rapid and automated quality control of their materials.
The results of the study, led by Illinois civil and environmental engineering professor Nishant ...
New research out of VCU Massey Cancer Center indicates that many adolescent and young adult kidney cancer survivors are at a significantly elevated risk for heart issues.
Cardiovascular disease is a leading cause of health complications and death among adolescents and young adults (AYAs) diagnosed with cancer, where AYAs are characterized as patients between the ages of 15 and 39.
A study publishing July 5 in the Journal of the National Comprehensive Cancer Network assessed the incidence and risk of hypertension — high blood pressure — and heart failure among AYA patients diagnosed ...
